RNS Number : 5652Y
NetScientific PLC
09 September 2015
 

 

NetScientific plc

 

 

NetScientific announces the key appointment of Steve Curd as CEO of Wanda, Inc.

 

London, UK - 9 September 2015 - NetScientific plc ("NetScientific" or the "Group", AIM: NSCI), the transatlantic biomedical and healthcare technology group, announces the appointment of Steve Curd as CEO of its portfolio company, Wanda, and head of the Group's Digital Health franchise, of which Wanda is the key asset.

Wanda helps healthcare providers improve outpatient care while reducing the costs associated with managing chronic diseases. The company provides a cloud based patient management solution combining comprehensive data-mining and advanced analytics to give clinicians a complete view of their outpatients' current and trending health. Its first medical product is Wanda™ CHF, a clinical decision support system for remotely managing patients with Congestive Heart Failure to help prevent hospital readmissions.

Steve Curd will join the Group on 14th September 2015 to oversee the growth and delivery of its digital health portfolio. He has more than 20 years' experience in driving growth for digital healthcare, commercialising products and delivering exits. Steve has helped secure 15 M&A transactions and numerous successful exits for Digital Health companies. Most recently, Steve was the COO of NantHealth, a healthcare company converging biomolecular medicine and bioinformatics with technology services, where he was responsible for advancing its product portfolio, driving improvements in efficiency and improving client satisfaction. Prior to that, he was CEO at CareInSync, an innovative mobile care coordination platform start-up where he grew the team, refined the business model and improved sales. Other notable positions include CIO at UnitedHealth Group, COO at WebMD, and CEO at VantageMed.

Francois Martelet, Group CEO of NetScientific, commented: "I am delighted to welcome a leader of Steve's calibre to the Group to drive the commercialisation programme for Wanda, our game-changing clinical decision support system. Steve is highly regarded in this area and will play a key role in accelerating the growth of our digital health portfolio, one of our three areas of strategic focus together with diagnostics and therapeutics."

Steve Curd commented: "Wanda represents the next generation of digital health solutions for patient care and I'm excited about the opportunity to drive its commercialisation phase. I look forward to working with NetScientific's diverse mix of digital health companies as its technologies have a real potential to become first or best in class technologies that could improve the lives of millions of people living with chronic diseases." 

- Ends -

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.

For more information, please visit the website at www.netscientific.net. 

 

About Wanda Health

Wanda Health (Wanda, Inc.) is developing cloud-based analytics, as part of a total patient management solution, in partnership with other healthcare providers. The core analytics engine is based on 12 years of research at the Wireless Health Institute at UCLA. Wanda Health has completed development of a predictive analytics engine for use in remotely monitoring patients with Congestive Heart Failure, the leading cause of hospital re-admissions in USA.

 

Contact Details

NetScientific

Peter Thoms, CFO

Tel: +44 (0)77 2055 5752

Investec

Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000

Instinctif Partners

Melanie Toyne-Sewell / Jayne Crook

Tel: +44 (0)20 7457 2020 Email: netscientific@instinctif.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSLFFUFISELU